更新了对寨卡病毒疫苗开发的最新审查
Hyun Jung Lee1, Sazaly Abu Bakar2, Ok Sarah Shin1,3
1BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Korea.
Clinical and experimental vaccine research
|November 12, 2025
概括
尽管它与小头症有关,但目前还没有批准的寨卡病毒 (ZIKV) 疫苗. 本综述涵盖了ZIKV疫苗平台的进展,这对于未来的流行病准备至关重要.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 寨卡病毒 (ZIKV) 感染在2015-2016年流行期间引起了严重的公共卫生问题,因为它与小头症和吉兰-巴雷综合征有关.
- 尽管存在已知的威胁,但目前还没有批准ZIKV疫苗,这使得人口容易受到持续传播和潜在的未来疫情的影响.
研究的目的:
- 审查各种ZIKV疫苗平台的最新进展.
- 评估ZIKV疫苗开发的现状及其对大流行病应对的影响.
主要方法:
- 关于ZIKV疫苗开发的科学文献的综述.
- 对各种疫苗平台的分析,包括无活化,活衰减,DNA,mRNA,病毒载体和复合子单元疫苗.
- 检查正在临床试验中的候选人.
主要成果:
- 使用不同平台的几个ZIKV疫苗候选人已经显示出有前途,并进入临床试验.
- 目前正在探索多种疫苗技术,这表明研究和开发环境强.
- 开发管道包括非活化,活衰减,DNA,mRNA,病毒载体和复合子单元方法.
结论:
- 对多个ZIKV疫苗平台的持续研究对于解决当前疾病传播和为未来的流行病做准备至关重要.
- 疫苗方法的多样性为快速应对新出现的病毒威胁提供了强大的策略.
- 持续投资和ZIKV疫苗开发的进展对于全球卫生安全至关重要.
相关概念视频
Vaccinations
Overview
FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...


